Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Oct;85(20):7521-5.
doi: 10.1073/pnas.85.20.7521.

Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity

Affiliations

Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity

M Pizza et al. Proc Natl Acad Sci U S A. 1988 Oct.

Abstract

The toxicity of pertussis toxin is mediated by the ADP-ribosyltransferase activity of subunit S1. To understand the structure-function relationship of subunit S1 and guide the construction of nontoxic molecules suitable for vaccines, we constructed and expressed in Escherichia coli a series of amino-terminal and carboxyl-terminal deletion mutants as well as a number of molecules containing amino acid substitutions. The shortest peptide still retaining enzymatic activity contains amino acids 2-179. Within this region we identified three mutants in which amino acid substitutions abolish the enzymatic activity. Mutation of amino acids 8 and 9 or 50 and 53, located within the region of the S1 subunit of pertussis toxin homologous to cholera toxin, causes loss of enzymatic activity. Outside this homology region, substitution of Glu-129 with glycine or aspartic acid also eliminates the enzymatic activity of the S1 subunit. In this respect, Glu-129 resembles the glutamic acid that is crucial for the catalytic activity of diphtheria and Pseudomonas toxins. Once introduced into the Bordetella pertussis chromosome, the above mutations should lead to the synthesis of nontoxic pertussis toxin molecules suitable for vaccine production.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1983 Nov;80(22):6853-7 - PubMed
    1. Mol Microbiol. 1988 Mar;2(2):293-6 - PubMed
    1. Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S992-7 - PubMed
    1. J Biol Chem. 1984 Jan 10;259(1):23-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 May;81(9):2645-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources